Control of alternative splicing by forskolin through hnRNP K during neuronal differentiation

Nucleic Acids Research

Volumn 40, Issue 16, 2012, Pages 8059-8071

  Cao, Wenguang ^a   Razanau, Aleh ^a   Feng, Dairong ^a   Lobo, Vincent G ^a   Xie, Jiuyong ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FORSKOLIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; NUCLEAR PROTEIN; PROTEIN U2AF65; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; EXON; GENE; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; RAT; RNA STRUCTURE; SNAP25 GENE; SPLICEOSOME;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXONS; FORSKOLIN; HEK293 CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; HUMANS; MOLECULAR SEQUENCE DATA; NERVOUS SYSTEM DISEASES; NEURITES; NEUROGENESIS; NEURONS; NUCLEAR PROTEINS; NUCLEOTIDE MOTIFS; PC12 CELLS; RATS; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RIBONUCLEOPROTEINS; RNA SPLICE SITES; SEQUENCE ALIGNMENT; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25;

RATTUS;

EID: 84870509497     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks504     Document Type: Article

References (75)

1. Graveley, B.R. (2001) Alternative splicing: increasing diversity in the proteomic world. Trends Genet., 17, 100-107.
2. Maniatis, T. and Tasic, B. (2002) Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature, 418, 236-243.
3. Black, D.L. (2003) Mechanisms of alternative pre-messenger rna splicing. Annu. Rev. Biochem., 72, 291-336.
4. Wang, E.T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S.F., Schroth, G.P. and Burge, C.B. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature, 456, 470-476.
5. Tazi, J., Bakkour, N. and Stamm, S. (2009) Alternative splicing and disease. Biochim. Biophys. Acta, 1792, 14-26.
6. Cooper, T.A., Wan, L. and Dreyfuss, G. (2009) RNA and disease. Cell, 136, 777-793.
7. Grabowski, P.J. and Black, D.L. (2001) Alternative RNA splicing in the nervous system. Prog. Neurobiol., 65, 289-308.
8. Li, Q., Lee, J.A. and Black, D.L. (2007) Neuronal regulation of alternative pre-mRNA splicing. Nat. Rev. Neurosci., 8, 819-831.
9. Heyd, F. and Lynch, K.W. (2011) Degrade, move, regroup: signaling control of splicing proteins. Trends Biochem. Sci., 36, 397-404.
10. Stamm, S. (2008) Regulation of alternative splicing by reversible protein phosphorylation. J. Biol. Chem., 283, 1223-1227.
11. Shin, C. and Manley, J.L. (2004) Cell signalling and the control of pre-mRNA splicing. Nat. Rev. Mol. Cell. Biol., 5, 727-738.
12. Smith, C.W. and Valcarcel, J. (2000) Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem. Sci., 25, 381-388.
13. Wang, Z. and Burge, C.B. (2008) Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA, 14, 802-813.
14. Moore, M.J. (2000) Intron recognition comes of AGe. Nat. Struct. Biol., 7, 14-16.
15. Tronchere, H., Wang, J. and Fu, X.-D. (1997) A protein related to splicing factor U2AF-35 that interacts with U2AF-65 and SR proteins in splicing of pre-mRNA. Nature (London), 388, 397-400.
16. Singh, R., Banerjee, H. and Green, M.R. (2000) Differential recognition of the polypyrimidine-tract by the general splicing factor U2AF65 and the splicing repressor sex-lethal. RNA, 6, 901-911.
17. Singh, R., Valcarcel, J. and Green, M.R. (1995) Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science, 268, 1173-1176.
18. Valcarcel, J., Singh, R., Zamore, P.D. and Green, M.R. (1993) The protein Sex-lethal antagonizes the splicing factor U2AF to regulate alternative splicing of transformer pre-mRNA. Nature, 362, 171-175.
19. Shepard, J., Reick, M., Olson, S. and Graveley, B.R. (2002) Characterization of U2AF26, a splicing factor related to U2AF35. Mol. Cell. Biol., 22, 221-230.
20. Corsini, L., Bonnal, S., Basquin, J., Hothorn, M., Scheffzek, K., Valcarcel, J. and Sattler, M. (2007) U2AF-homology motif interactions are required for alternative splicing regulation by SPF45. Nat. Struct. Mol. Biol., 14, 620-629.
21. Lallena, M.J., Chalmers, K.J., Llamazares, S., Lamond, A.I. and Valcarcel, J. (2002) Splicing regulation at the second catalytic step by Sex-lethal involves 3' splice site recognition by SPF45. Cell, 109, 285-296.
22. Heiner, M., Hui, J., Schreiner, S., Hung, L.H. and Bindereif, A. (2010) HnRNP L-mediated regulation of mammalian alternative splicing by interference with splice site recognition. RNA Biol., 7, 56-64.
23. Warf, M.B., Diegel, J.V., von Hippel, P.H. and Berglund, J.A. (2009) The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing. Proc. Natl Acad. Sci. USA, 106, 9203-9208.
24. Thisted, T., Lyakhov, D.L. and Liebhaber, S.A. (2001) Optimized RNA targets of two closely related triple KH domain proteins, heterogeneous nuclear ribonucleoprotein K and alphaCP-2KL, suggest Distinct modes of RNA recognition. J. Biol. Chem., 276, 17484-17496.
25. Han, S.P., Tang, Y.H. and Smith, R. (2010) Functional diversity of the hnRNPs: past, present and perspectives. Biochem. J., 430, 379-392.
26. Martinez-Contreras, R., Cloutier, P., Shkreta, L., Fisette, J.F., Revil, T. and Chabot, B. (2007) hnRNP proteins and splicing control. Adv. Exp. Med. Biol., 623, 123-147.
27. Revil, T., Pelletier, J., Toutant, J., Cloutier, A. and Chabot, B. (2009) Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform. J. Biol. Chem., 284, 21458-21467.
28. Expert-Bezancon, A., Le Caer, J.P. and Marie, J. (2002) Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a component of an intronic splicing enhancer complex that activates the splicing of the alternative exon 6A from chicken beta-tropomyosin pre-mRNA. J. Biol. Chem., 277, 16614-16623.
29. Venables, J.P., Koh, C.S., Froehlich, U., Lapointe, E., Couture, S., Inkel, L., Bramard, A., Paquet, E.R., Watier, V., Durand, M. et al. (2008) Multiple and specific mRNA processing targets for the major human hnRNP proteins. Mol. Cell. Biol., 28, 6033-6043.
30. Xie, J. and Black, D.L. (2001) A CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels. Nature, 410, 936-939.
31. Yu, J., Hai, Y., Liu, G., Fang, T., Kung, S.K. and Xie, J. (2009) The heterogeneous nuclear ribonucleoprotein L is an essential component in the Ca++/calmodulin-dependent protein kinase IV-regulated alternative splicing through cytidine-adenosine repeats. J. Biol. Chem., 284, 1505-1513.
32. Li, H., Liu, G., Yu, J., Cao, W., Lobo, V.G. and Xie, J. (2009) In vivo selection of kinase-responsive RNA elements controlling alternative splicing. J. Biol. Chem., 284, 16191-16201.
33. Xie, J. (2008) Control of alternative pre-mRNA splicing by Ca(++) signals. Biochim. Biophys. Acta, 1779, 438-452.
34. Xie, J., Lee, J.A., Kress, T.L., Mowry, K.L. and Black, D.L. (2003) Protein kinase A phosphorylation modulates transport of the polypyrimidine tract-binding protein. Proc. Natl Acad. Sci. USA, 100, 8776-8781.
35. Hai, Y., Cao, W., Liu, G., Hong, S.P., Elela, S.A., Klinck, R., Chu, J. and Xie, J. (2008) A G-tract element in apoptotic agents-induced alternative splicing. Nucleic Acids Res., 36, 3320-3331.
36. Cao, W.G., Sohail, M., Liu, G., Koumbadinga, G.A., Lobo, V.G. and Xie, J.Y. (2011) Differential effects of PKA-controlled CaMKK2 variants on neuronal differentiation. RNA Biol., 86, 1061-1072.
37. Ma, S., Liu, G., Sun, Y. and Xie, J. (2007) Relocalization of the polypyrimidine tract-binding protein during PKA-induced neurite growth. Biochim. Biophys. Acta, 1773, 912-923.
38. Benderska, N., Becker, K., Girault, J.A., Becker, C.M., Andreadis, A. and Stamm, S. (2010) DARPP-32 binds to tra2-beta1 and influences alternative splicing. Biochim. Biophys. Acta, 1799, 448-453.
39. Kvissel, A.K., Orstavik, S., Eikvar, S., Brede, G., Jahnsen, T., Collas, P., Akusjarvi, G. and Skalhegg, B.S. (2007) Involvement of the catalytic subunit of protein kinase A and of HA95 in pre-mRNA splicing. Exp. Cell. Res., 313, 2795-2809.
40. Shi, J., Qian, W., Yin, X., Iqbal, K., Grundke-Iqbal, I., Gu, X., Ding, F., Gong, C.X. and Liu, F. (2011) Cyclic AMP-dependent Protein Kinase Regulates the Alternative Splicing of Tau Exon 10: a mechanism involved in tau pathology of Alzheimer disease. J. Biol. Chem., 286, 14639-14648.
41. Jarnaess, E., Stokka, A.J., Kvissel, A.K., Skalhegg, B.S., Torgersen, K.M., Scott, J.D., Carlson, C.R. and Tasken, K. (2009) Splicing factor arginine/serine-rich 17A (SFRS17A) is an A-kinase anchoring protein that targets protein kinase A to splicing factor compartments. J. Biol. Chem., 284, 35154-35164.
42. Habelhah, H., Shah, K., Huang, L., Ostareck-Lederer, A., Burlingame, A.L., Shokat, K.M., Hentze, M.W. and Ronai, Z. (2001) ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat. Cell. Biol., 3, 325-330.
43. Hall-Pogar, T., Liang, S., Hague, L.K. and Lutz, C.S. (2007) Specific trans-acting proteins interact with auxiliary RNA polyadenylation elements in the COX-2 3'-UTR. RNA, 13, 1103-1115.
44. Qin, X.F., An, D.S., Chen, I.S. and Baltimore, D. (2003) Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl Acad. Sci. USA, 100, 183-188.
45. Bark, C., Bellinger, F.P., Kaushal, A., Mathews, J.R., Partridge, L.D. and Wilson, M.C. (2004) Developmentally regulated switch in alternatively spliced SNAP-25 isoforms alters facilitation of synaptic transmission. J. Neurosci., 24, 8796-8805.
46. Johansson, J.U., Ericsson, J., Janson, J., Beraki, S., Stanic, D., Mandic, S.A., Wikstrom, M.A., Hokfelt, T., Ogren, S.O., Rozell, B. et al. (2008) An ancient duplication of exon 5 in the Snap25 gene is required for complex neuronal development/function. PLoS Genet., 4, e1000278.
47. Hepp, R., Dupont, J.L., Aunis, D., Langley, K. and Grant, N.J. (2001) NGF enhances depolarization effects on SNAP-25 expression: induction of SNAP-25b isoform. Neuroreport, 12, 673-677.
48. Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T. and Hidaka, H. (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem., 265, 5267-5272.
49. Xie, J. and McCobb, D.P. (1998) Control of alternative splicing of potassium channels by stress hormones. Science (Washington, DC), 280, 443-446.
50. Perkins, D.N., Pappin, D.J., Creasy, D.M. and Cottrell, J.S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis, 20, 3551-3567.
51. Kim, N., Alekseyenko, A.V., Roy, M. and Lee, C. (2007) The ASAP II database: analysis and comparative genomics of alternative splicing in 15 animal species. Nucleic Acids Res, 35, D93-8.
52. Marmigere, F., Montelius, A., Wegner, M., Groner, Y., Reichardt, L.F. and Ernfors, P. (2006) The Runx1/AML1 transcription factor selectively regulates development and survival of TrkA nociceptive sensory neurons. Nat. Neurosci., 9, 180-7.
53. Marmigere, F. and Ernfors, P. (2007) Specification and connectivity of neuronal subtypes in the sensory lineage. Nat. Rev. Neurosci., 8, 114-127.
54. Theriault, F.M., Nuthall, H.N., Dong, Z., Lo, R., Barnabe-Heider, F., Miller, F.D. and Stifani, S. (2005) Role for Runx1 in the proliferation and neuronal differentiation of selected progenitor cells in the mammalian nervous system. J. Neurosci., 25, 2050-2061.
55. Kramer, I., Sigrist, M., de Nooij, J.C., Taniuchi, I., Jessell, T.M. and Arber, S. (2006) A role for Runx transcription factor signaling in dorsal root ganglion sensory neuron diversification. Neuron, 49, 379-393.
56. Kobayashi, A., Senzaki, K., Ozaki, S., Yoshikawa, M. and Shiga, T. (2011) Runx1 promotes neuronal differentiation in dorsal root ganglion. Mol. Cell. Neurosci., 49, 23-31.
57. Stifani, N., Freitas, A.R., Liakhovitskaia, A., Medvinsky, A., Kania, A. and Stifani, S. (2008) Suppression of interneuron programs and maintenance of selected spinal motor neuron fates by the transcription factor AML1/Runx1. Proc. Natl Acad. Sci. USA, 105, 6451-6456.
58. Vilardell, M., Rasche, A., Thormann, A., Maschke-Dutz, E., Perez-Jurado, L.A., Lehrach, H. and Herwig, R. (2011) Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes. BMC Genomics, 12, 229.
59. Katzaki, E., Morin, G., Pollazzon, M., Papa, F.T., Buoni, S., Hayek, J., Andrieux, J., Lecerf, L., Popovici, C., Receveur, A. et al. (2010) Syndromic mental retardation with thrombocytopenia due to 21q22.11q22.12 deletion: report of three patients. Am. J. Med. Genet. A., 152A, 1711-1717.
60. Lindstrand, A., Malmgren, H., Sahlen, S., Schoumans, J., Nordgren, A., Ergander, U., Holm, E., Anderlid, B.M. and Blennow, E. (2010) Detailed molecular and clinical characterization of three patients with 21q deletions. Clin. Genet, 77, 145-154.
61. Beri-Dexheimer, M., Latger-Cannard, V., Philippe, C., Bonnet, C., Chambon, P., Roth, V., Gregoire, M.J., Bordigoni, P., Lecompte, T., Leheup, B. et al. (2008) Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions. Eur. J. Hum. Genet., 16, 1014-1018.
62. Cryan, J.F. and Slattery, D.A. (2010) GABAB receptors and depression. Current status. Adv. Pharmacol., 58, 427-451.
63. Silva, J.P. and Ushkaryov, Y.A. (2010) The latrophilins, ''split-personality'' receptors. Adv. Exp. Med. Biol., 706, 59-75.
64. Lutterbach, B., Westendorf, J.J., Linggi, B., Isaac, S., Seto, E. and Hiebert, S.W. (2000) A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J. Biol. Chem., 275, 651-656.
65. Mackereth, C.D., Madl, T., Bonnal, S., Simon, B., Zanier, K., Gasch, A., Rybin, V., Valcarcel, J. and Sattler, M. (2011) Multi-domain conformational selection underlies pre-mRNA splicing regulation by U2AF. Nature, 475, 408-411.
66. Mikhail, F.M., Sinha, K.K., Saunthararajah, Y. and Nucifora, G. (2006) Normal and transforming functions of RUNX1: a perspective. J. Cell. Physiol., 207, 582-593.
67. Giguere, A. and Hebert, J. CLCA2, a novel RUNX1 partner gene in a therapy-related leukemia with t(1;21)(p22;q22). Cancer Genet. Cytogenet, 202, 94-100.
68. Mikhail, F.M., Coignet, L., Hatem, N., Mourad, Z.I., Farawela, H.M., El Kaffash, D.M., Farahat, N. and Nucifora, G. (2004) A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer, 39, 110-118.
69. Nucifora, G., Begy, C.R., Kobayashi, H., Roulston, D., Claxton, D., Pedersen-Bjergaard, J., Parganas, E., Ihle, J.N. and Rowley, J.D. (1994) Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc. Natl Acad. Sci. USA, 91, 4004-4008.
70. Zhang, Y., Emmanuel, N., Kamboj, G., Chen, J., Shurafa, M., Van Dyke, D.L., Wiktor, A. and Rowley, J.D. (2004) PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22). Genes Chromosomes Cancer, 40, 365-370.
71. Sacchi, N., Nisson, P.E., Watkins, P.C., Faustinella, F., Wijsman, J. and Hagemeijer, A. (1994) AML1 fusion transcripts in t(3;21) positive leukemia: evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AML1 transcripts. Genes Chromosomes Cancer, 11, 226-236.
72. Liu, Y., Gervasi, C. and Szaro, B.G. (2008) A crucial role for hnRNP K in axon development in Xenopus laevis. Development, 135, 3125-3135.
73. Liu, Y. and Szaro, B.G. (2011) hnRNP K post-transcriptionally co-regulates multiple cytoskeletal genes needed for axonogenesis. Development, 138, 3079-3090.
74. Gabut, M., Samavarchi-Tehrani, P., Wang, X., Slobodeniuc, V., O'Hanlon, D., Sung, H.K., Alvarez, M., Talukder, S., Pan, Q., Mazzoni, E.O. et al. (2011) An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell, 147, 132-146.
75. Raj, B., O'Hanlon, D., Vessey, J.P., Pan, Q., Ray, D., Buckley, N.J., Miller, F.D. and Blencowe, B.J. (2011) Cross-regulation between an alternative splicing activator and a transcription repressor controls neurogenesis. Mol. Cell., 43, 843-850.